OptiNose Inc (OPTN)
1.085
0.00 (0.00%)
USD |
NASDAQ |
Jun 03, 16:00
1.085
0.00 (0.00%)
After-Hours: 20:00
OptiNose Net Income (TTM): -30.70M for March 31, 2024
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | -30.70M |
| December 31, 2023 | -35.48M |
| September 30, 2023 | -40.66M |
| June 30, 2023 | -46.32M |
| March 31, 2023 | -68.35M |
| December 31, 2022 | -74.83M |
| September 30, 2022 | -75.31M |
| June 30, 2022 | -77.47M |
| March 31, 2022 | -81.58M |
| December 31, 2021 | -82.30M |
| September 30, 2021 | -90.54M |
| June 30, 2021 | -94.63M |
| March 31, 2021 | -96.98M |
| December 31, 2020 | -99.78M |
| Date | Value |
|---|---|
| September 30, 2020 | -100.92M |
| June 30, 2020 | -108.51M |
| March 31, 2020 | -110.04M |
| December 31, 2019 | -110.05M |
| September 30, 2019 | -111.44M |
| June 30, 2019 | -107.76M |
| March 31, 2019 | -104.96M |
| December 31, 2018 | -106.66M |
| September 30, 2018 | -99.83M |
| June 30, 2018 | -87.77M |
| March 31, 2018 | -71.40M |
| December 31, 2017 | -48.90M |
| September 30, 2017 | -34.94M |
| June 30, 2017 | -27.98M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-111.44M
Minimum
Sep 2019
-30.70M
Maximum
Mar 2024
-82.18M
Average
-86.42M
Median
Net Income (TTM) Benchmarks
| Madrigal Pharmaceuticals Inc | -444.28M |
| Viking Therapeutics Inc | -93.72M |
| Zevra Therapeutics Inc | -50.90M |
| CytomX Therapeutics Inc | 16.53M |
| Spero Therapeutics Inc | 23.40M |